
Weight-Loss Drugs Divide Wall Street on Medical Device Stocks
With weight-loss drugs that reduce the risk of heart attacks and diabetes potentially improving millions of lives, stock investors have had the somewhat unpleasant task of sussing out the impact on a host of health-care companies.